Japan (State or other jurisdiction of incorporation) | 000-55133 (Commission File Number) | 98-1295657 (IRS Employer Identification No.) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): | |
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.07 | Submission of Matters to a Vote of Security Holders |
1. | To approve the amendment to the Articles of Incorporation of the Company to reflect the change in location of the Company’s head office: |
Votes For | Votes Against | Abstentions | Broker Non-Votes |
302,900 | 671 | — | — |
2. | To elect the five nominees to the Board of Directors, each to serve a one-year term |
Nominee | Votes For | Votes Against | Abstentions | Broker Non-Votes |
Shintaro Asako | 302,475 | 926 | — | — |
Ryo Kubota, M.D., Ph.D. | 302,540 | 861 | — | — |
Shiro Mita | 302,528 | 873 | — | — |
Eisaku Nakamura | 302,512 | 889 | — | — |
Robert Takeuchi | 302,500 | 901 | — | — |
Item 8.01 | Other Events. |
Item 9.01 | Financial Statements and Exhibits. | ||
(d) Exhibits. | |||
Exhibit Number | Description | ||
99.1 | Extraordinary report dated May 26, 2017. |
KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD. | ||
Date: May 26, 2017 | ||
By: | /s/ John E. Gebhart | |
John E. Gebhart | ||
Chief Financial Officer |
Exhibit Number | Description | |
99.1 | Extraordinary report dated May 26, 2017. |
Documents to be filed | Extraordinary Report |
To be filed with: | Director General of Kanto Local Finance Bureau |
Date of filing: | May 26, 2017 |
Company Name: | Kubota Pharmaceutical Holdings Co., Ltd. |
Title and name of representative: | Dr. Ryo Kubota, Representative Executive Officer, Chairman, President and Chief Executive Officer |
Address of headquarters: | Yebisu Garden Place Tower 18F, 4-20-3 Ebisu, Shibuya-ku |
Tokyo 150-6018, Japan | |
Telephone number: | 03-5789-5872 |
Contact person: | Yasuo Ishikawa, Director of Financial Reporting |
Japan Office | |
Place of contact: | Yebisu Garden Place Tower 18F, 4-20-3 Ebisu, Shibuya-ku |
Tokyo 150-6018, Japan | |
Telephone number: | 03-5789-5872 |
Places where the document to be filed is available for public inspection: | Tokyo Stock Exchange, Inc. (2-1, Nihonbashi-kabutocho, Chuo-ku, Tokyo) |
Agenda | For | Against | Abstention | Requirement for the approval | Results and Ratio of favorable votes |
Agenda 1 | 302,900 | 671 | — | Note 1 | Approved 99.25% |
Agenda 2 | |||||
Ryo Kubota | 302,540 | 861 | — | Approved 99.13% | |
Shintaro Asako | 302,475 | 926 | — | Note 2 | Approved 99.11% |
Shiro Mita | 302,528 | 873 | — | Approved 99.13% | |
Eisaku Nakamura | 302,512 | 889 | — | Approved 99.12% | |
Robert Takeuchi | 302,500 | 901 | — | Approved 99.12% |